Dendritic cell-lysosomal-associated membrane protein (LAMP) and LAMP-1-HIV-1 Gag chimeras have distinct cellular trafficking pathways and prime T and B cell responses to a diverse repertoire of epitopes

Journal of Immunology

Volumn 177, Issue 4, 2006, Pages 2265-2275

  Arruda, Luciana B ^a,b   Sim, Del ^c   Chikhlikar, Priya R ^a   Maciel Jr , Milton ^a   Akasaki, Kenji ^d   August, J Thomas ^a,c   Marques, Ernesto T A ^a,e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c Johns Hopkins Singapore   (Singapore)

^d FUKUYAMA UNIVERSITY   (Japan)

^e INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALOXISTATIN ACID; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BREFELDIN A; CD4 ANTIGEN; CD8 ANTIGEN; CHLOROQUINE; EPITOPE; GAG PROTEIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PLASMID DNA; PROTEIN P55GAG; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL TRANSPORT; CHIMERA; CONTROLLED STUDY; DENDRITIC CELL; DRUG POTENCY; ENDOSOME; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; LYSOSOME; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; T LYMPHOCYTE ACTIVATION; TH1 CELL;

EID: 33746930264     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.4.2265     Document Type: Article

References (69)

1. Watts, C. 1997. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu. Rev. Immunol. 15: 821-850.
2. Guermonprez, P., J. Valladeau, L. Zitvogel, C. Thery, and S. Amigorena. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20: 621-667.
3. Jondal, M., R. Schirmbeck, and J. Reimann. 1996. MHC class I-restricted CTL responses to exogenous antigens. Immunity 5: 295-294.
4. Heath, W. R., and F. R. Carbone. 2001. Cross-presentation in viral immunity and self-tolerance. Nat. Rev. Immunol. 1: 126-124.
5. Schirmbeck, R., and J. Reimann, 2002. Alternative processing of endogenous or exogenous antigens extends the immunogenic, H-2 class I-restricted peptide repertoire. Mol. Immunol. 39: 249-259.
6. Rock, K. L., I. A. York, and A. L. Goldberg. 2004. Post-proteasomal antigen processing for major histocompatibility complex class I presentation. Nat. Immunol. 5: 670-677.
7. Kloetzel, P. M., and F. Ossendorp. 2004. Proteasome and peptidase function in MHC-class-I-mediated antigen presentation. Curr. Opin. Immunol. 16: 76-81.
8. Watts, C. 2004. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CDI molecules. Nat. Immunol. 5: 685-692.
9. Underbill, D. M., and A. Ozinsky. 2002. Phagocytosis of microbes: complexity in action. Annu. Rev. Immunol. 20: 825-824.
10. Ackerman, A. L., and P. Cresswell. 2004. Cellular mechanisms governing cross-presentation of exogenous antigens. Nat. Immunol. 5: 678-684.
11. Harding, C. V., L. Ramachandra, and M. J. Wick. 2003. Interaction of bacteria with antigen presenting cells: influences on antigen presentation and antibacterial immunity. Curr. Opin. Immunol. 15: 112-119.
12. + T cells by cytosolic mechanisms in dendritic cells versus vacuolar mechanisms in macrophages. J. Immunol. 172: 5277-5286.
13. Potter, N. S., and C. V. Harding. 2001. Neutrophils process exogenous bacteria via an alternate class I MHC processing pathway for presentation of peptides to T lymphocytes. J. Immunol. 167: 2538-2546.
14. Chen, L., and M. Jondal. 2004. Alternative processing for MHC class I presentation by immature and CpG-activated dendritic cells. Eur. J. Immunol. 34: 952-960.
15. Chen, L., and M. Jondal. 2004. Endolysosomal processing of exogenous antigen into major histocompatibility complex class I-binding peptides. Scand. J. Immunol. 59: 545-552.
16. Perrin-Cocon, L. A., C. L. Villiers, J. Salamero, F. Gabert, and P. N. Marche. 2004. B cell receptors and complement receptors target the antigen to distinct intracellular compartments. J. Immunol. 172: 3564-3572.
17. Mahnke, K., M. Guo, S. Lee, H. Sepulveda, S. L. Swain, M. Nussenzweig, and R. M. Steinman. 2000. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J. Cell Biol. 151: 673-684.
18. Lautwein, A., M. Kraus, M. Reich, T. Burster, J. Brandenburg, H. S. Overkleeft, G. Schwarz, W. Kammer, E. Weber, H. Kalbacher, et al. 2004. Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S-independent manner. J. Leukocyte Biol. 75: 844-855.
19. Lautwein, A., T. Burster, A. M. Lennon-Dumenil, H. S. Overkleeft, E. Weber, H. Kalbacher, and C. Driessen. 2002. Inflammatory stimuli recruit cathepsin activity to late endosomal compartments in human dendritic cells. Eur. J. Immunol. 32: 3348-3357.
20. Claus, V., A. Jahraus, T. Tjelle, T. Berg, H. Kirschke, H. Faulstich, and G. Griffiths. 1998. Lysosomal enzyme trafficking between phagosomes, endosomes, and lysosomes in J774 macrophages: enrichment of cathepsin H in early endosomes. J. Biol. Chem. 273: 9842-9851.
21. De Stefanis, D., M. Demoz, A. Dragonetti, J. J. Houri, E. Ogier-Denis, P. Codogno, F. M. Baccino, and C. Isidoro. 1997. Differentiation-induced changes in the content, secretion, and subcellular distribution of lysosomal cathepsins in the human colon cancer HT-29 cell line. Cell Tissue Res. 289: 109-117.
22. Lu, Y., K. Raviprakash, I. C. Leao, P. R. Chikhlikar, D. Ewing, A. Anwar, C. Chougnet, G. Murphy, C. G. Hayes, T. J. August, and E. T. Marques, Jr. 2003. Dengue 2 PreM-E/LAMP chimera targeted to the MHC class II compartment elicits long-lasting neutralizing antibodies. Vaccine 21: 2178-2189.
23. Fernandes, D. M., L. Vidard, and K. L. Rock. 2000. Characterization of MHC class II-presented peptides generated from an antigen targeted to different endocytic compartments. Eur. J. Immunol. 30: 2333-2343.
24. Marques, E. T., Jr., P. Chikhlikar, L. B. de Arruda, I. C. Leao, Y. Lu, J. Wong, J. S. Chen, B. Byrne, and J. T. August. 2003. HIV-1 p55Gag encoded in the lysosome-associated membrane protein-1 as a DNA plasmid vaccine chimera is highly expressed, traffics to the major histocompatibility class II compartment, and elicits enhanced immune responses. J. Biol. Chem. 278: 37926-37936.
25. Boyle, J. S., C. Koniaras, and A. M. Lew. 1997. Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intra muscular DNA immunization. Int. Immunol. 9: 1897-1906.
26. Lewis, P. J., H. van Drunen Littel-van den, and L. A. Babiuk. 1999. Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response. J. Virol. 73: 10214-10223.
27. + T cell populations with differing cytolytic activities. J. Virol. 15: 7399-7409.
28. + responses to a HIV-1 p55Gag/LAMP DNA vaccine chimera. Virology 323: 220-232.
29. de Arruda, L. B., P. R. Chikhlikar, J. T. August, and E. T. Marques. 2004. DNA vaccine encoding human immunodeficiency virus-1 Gag. targeted to the major histocompatibility complex II compartment by lysosomal-associated membrane protein, elicits enhanced long-term memory response. Immunology 112: 126-133.
30. Raviprakash, K., E. Marques, D. Ewing, Y. Lu, I. Phillips, K. R. Porter, T. J. Kochel, T. J. August, C. G. Hayes, and G. S. Murphy. 2001. Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF. Virology 290: 74-82.
31. Ruff, A. L., F. G. Guarnieri, K. Staveley-O'Carroll, R. F. Siliciano, and J. T. August. 1997. The enhanced immune response to the HIV gp160/LAMP chimeric gene product targeted to the lysosome membrane protein trafficking pathway. J. Biol. Chem. 272: 8671-8678.
32. Wu, T. C., F. G. Guarnieri, K. F. Staveley-O'Carroll, R. P. Viscidi, H. I. Levitsky, L. Hedrick, K. R. Cho, J. T. August, and D. M. Pardoll. 1995. Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens. Proc. Natl. Acad. Sci. USA 92: 11671-11675.
33. Rowell, J. F., A. L. Ruff, F. G. Guarnieri, K. Staveley-O'Carroll, X. Lin, J. Tang, J. T. August, and R. F. Siliciano. 1995. Lysosome-associated membrane protein-I-mediated targeting of the HIV-1 envelope protein to an endosomal/lysosomal compartment enhances its presentation to MHC class II-restricted T cells. J. Immunol. 155: 1818-1828.
34. Wu, J. M., B. Wu, F. Guarnieri, J. T. August, and D. B. Drachman. 2000. Targeting antigen-specific T cells by genetically engineered antigen presenting cells: a strategy for specific immunotherapy of autoimmune disease. J. Neuroimmunol. 106: 145-153.
35. Nair, S. K., D. Boczkowski, M. Morse, R. I. Cumming, H. K. Lyerly, and E. Gilboa. 1998. Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. Nat. Biotechnol. 16: 364-369.
36. + T cells using dendritic cells transfected with RNA encoding a chimeric gene product. Cancer Res. 62: 5041-5048.
37. de Saint-Vis, B., J. Vincent, S. Vandenabeele, B. Vanbervliet, J. J. Pin, S. Ait-Yahia, S. Patel, M. G. Mattei, J. Banchereau, S. Zurawski, et al. 1998. A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity 9: 325-336.
38. Akasaki, K., N. Nakamura, N. Tsukui, S. Yokota, S. Murata, R. Katoh, A. Michihara, H. Tsuji, E. T. Marques, Jr., and J. T. August. 2004. Human dendritic cell lysosome-associated membrane protein expressed in lung type II pneumocytes. Arch. Biochem. Biophys. 425: 147-157.
39. Salaun, B., B. de Saint-Vis, N. Pacheco, Y. Pacheco, A. Riesler, S. Isaac, C. Leroux, V. Clair-Moninot, J. J. Pin, J. Griffith, et al. 2004. CD208/dendritic cell-lysosomal associated membrane protein is a marker of normal and transformed type II pneumocytes. Am. J. Pathol. 164: 861-871.
40. Barois, N., B. de Saint-Vis, S. Lebecque, H. J. Geuze, and M. J. Kleijmeer. 2002. MHC class II compartments in human dendritic cells undergo profound structural changes upon activation. Traffic 3: 894-905.
41. Kleijmeer, M. J., J. M. Escola, F. G. UytdeHaag, E. Jakobson, J. M. Griffith, A. D. Osterhaus, W. Stoorvogel, C. J. Melief, C. Rabouille, and H. J. Geuze. 2001. Antigen loading of MHC class I molecules in the endocytic tract. Traffic 2: 124-124.
42. Kessler, P. D., G. M. Podsakoff, X. Chen, S. A. McQuiston, P. C. Colosi, L. A. Matelis, G. J. Kurtzman, and B. J. Byrne. 1996. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. USA 93: 14082-14087.
43. Chen, J. W., T. L. Murphy, M. C. Willingham, I. Pastan, and J. T. August. 1985. Identification of two lysosomal membrane glycoproteins. J. Cell Biol. 101: 85-84.
44. Chen, J. W., W. Pan, M. P. D'Souza, and J. T. August. 1985. Lysosome-associated membrane proteins: characterization of LAMP-1 of macrophage P388 and mouse embryo 3T3 cultured cells. Arch. Biochem. Biophys. 239: 574-586.
45. Mane, S. M., L. Marzella, D. F. Bainton, V. K. Holt, Y. Cha, J. E. Hildreth, and J. T. August. 1989. Purification and characterization of human lysosomal membrane glycoproteins. Arch. Biochem. Biophys. 268: 360-378.
46. Lee, D. H., and A. L. Goldberg. 1998. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 8: 397-403.
47. d through interactions between a glutamine at P3 and pocket D. J. Immunol. 161: 2985-2993.
48. Eisen, H. N. 2001. Specificity and degeneracy in antigen recognition: yin and yang in the immune system. Annu. Rev. Immunol. 19: 1-21.
49. Chang, M. H., C. T. Hua, E. L. Isaac, T. Litjens, G. Hodge, L. E. Karageorgos, and P. J. Meikle. 2004. Transthyretin interacts with the lysosome-associated membrane protein (LAMP-1) in circulation. Biochem. J. 382: 481-489.
50. Meikle, P. J., M. Yan, E. M. Ravenscroft, E. L. Isaac, J. J. Hopwood, and D. A. Brooks. 1999. Altered trafficking and turnover of LAMP-1 in Pompe disease-affected cells. Mol. Genet Metab. 66: 179-188.
51. Akasaki, K., A. Michihara, K. Mibuka, Y. Fujiwara, and H. Tsuji. 1995. Biosynthetic transport of a major lysosomal membrane glycoprotein, lamp-1: convergence of biosynthetic and endocytic pathways occurs at three distinctive points. Exp. Cell Res. 220: 464-473.
52. Lippincott-Schwartz, J., and D. M. Fambrough. 1987. Cycling of the integral membrane glycoprotein, LEP100, between plasma membrane and lysosomes: kinetic and morphological analysis. Cell 49: 669-677.
53. Nguyen, D. G., A. Booth, S. J. Gould, and J. E. Hildreth. 2003. Evidence that HIV budding in primary macrophages occurs through the exosome release pathway. J. Biol. Chem. 278: 52347-52354.
54. Boes, M., J. Cerny, R. Massol, M. Op den Brouw, T. Kirchhausen, J. Chen, and H. L. Ploegh. 2002. T cell engagement of dendritic cells rapidly rearranges MHC class II transport. Nature 418: 983-988.
55. Chow, A., D. Toomre, W. Garrett, and I. Mellman. 2002. Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane. Nature 418: 988-994.
56. Murk, J. L., W. Stoorvogel, M. J. Kleijmeer, and H. J. Geuze. 2002. The plasticity of multivesicular bodies and the regulation of antigen presentation. Semin. Cell Dev. Biol. 13: 303-311.
57. Manoury, B., D. Mazzeo, L. Fugger, N. Viner, M. Ponsford, H. Streeter, G. Mazza, D. C. Wraith, and C. Watts. 2002. Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP. Nat. Immunol. 3: 169-174.
58. + T cell epitope hot spots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing. Proc. Natl. Acad. Sci. USA 98: 4587-4592.
59. Delvig, A. A., and J. H. Robinson. 1998. Different endosomal proteolysis requirements for antigen processing of two T cell epitopes of the M5 protein from viable Streptococcus pyogenes. J. Biol. Chem. 273: 3291-3295.
60. Delvig, A. A., J. J. Lee, Z. M. Chrzanowska-Lightowlers, and J. H. Robinson. 2002. TGF-β1 and IFN-γ cross-regulate antigen presentation to CD4 T cells by macrophages. J. Leukocyte Biol. 72: 163-166.
61. + T cells induced by a DNA vaccine: immunological consequences of epitope-specific lysosomal targeting. J. Virol. 75: 10421-10430.
62. Allen, T. M., D. H. O'Connor, P. Jing, J. L. Dzuris, B. R. Mothe, T. U. Vogel, E. Dunphy, M. E. Liebl, C. Emerson, N. Wilson, et al. 2000. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 407: 386-390.
63. Goulder, P. J., C. Brander, Y. Tang, C. Tremblay, R. A. Colbert, M. M. Addo, E. S. Rosenberg, T. Nguyen, R. Allen, A. Trocha, et al. 2001. Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 412: 334-338.
64. Barouch, D. H., J. Kunstman, M. J. Kuroda, J. E. Schmitz, S. Santra, F. W. Peyerl, G. R. Krivulka, K. Beaudry, M. A. Lifton, D. A. Gorgone, et al. 2002. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 415: 335-339.
65. Allen, T. M., M. Altfeld, X. G. Yu, K. M. O'Sullivan, M. Lichterfeld, S. Le Gall, M. John, B. R. Mothe, P. K. Lee, E. T. Kalife, et al. 2004. Selection, transmission, and reversion of an antigen-processing cytotoxic T lymphocyte escape mutation in human immunodeficiency virus type 1 infection. J. Virol. 78: 7069-7078.
66. Chouquet, C., B. Autran, E. Gomard, J. M. Bouley, V. Calvez, C. Katlama, D. Costagliola, and Y. Riviere. 2002. Correlation between breadth of memory HIV-specific cytotoxic T cells, viral load and disease progression in HIV infection. AIDS 16: 2399-2407.
67. Carrington, M., G. W. Nelson, M. P. Martin, T. Kissner, D. Vlahov, J. J. Goedert, R. Kaslow, S. Buchbinder, K. Hoots, and S. J. O'Brien. 1999. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 283: 1748-1752.
68. Santra, S., D. H. Barouch, M. J. Kuroda, J. E. Schmitz, G. R. Krivulka, K. Beaudry, C. I. Lord, M. A. Lifton, L. S. Wyatt, B. Moss, et al. 2002. Prior vaccination increases the epitopic breadth of the cytotoxic T lymphocyte response that evolves in rhesus monkeys following a simian-human immunodeficiency virus infection. J. Virol. 76: 6376-6381.
69. + T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef. Blood 107: 1963-1969.